Patents-Review.com
ClassID:

94941 ⎘

C07D303/40 - CPC Classification

Classification description:

Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom; Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals

Sub-classes:
Recent Application in this class:
#1
20250376430
2025-12-11

DIFLUOROALDEHYDE, EPOXY, AND DERIVATIVE THEREOF

 #2
20250129033
2025-04-24

METAP2 INHIBITORS AND USES THEREOF

 #3
20240025870
2024-01-25

PKC-ACTIVATING COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES

 #4
20220380298
2022-12-01

Inhibitors of the n-terminal domain of the androgen receptor

 #5
20220356161
2022-11-10

PKC-activating compounds for the treatment of neurodegenerative diseases

 #6
20200331875
2020-10-22

PKC-activating compounds for the treatment of neurodegenerative diseases

 #7
20200287239
2020-09-10

Graphene compound and manufacturing method thereof, electrolyte, and power storage device

 #8
20200285152
2020-09-10

Positive resist composition and patterning process

 #9
20200165218
2020-05-28

METHODS FOR MAKING CYCLOHEXENE OXIDE-CONTAINING ESTERS

 #10
20190388380
2019-12-26

FUMAGILLOL TYPE COMPOUNDS AND METHODS OF MAKING AND USING SAME

 #11
20190382335
2019-12-19

Inhibitors of the N-terminal domain of the androgen receptor

 #12
20190270715
2019-09-05

PKC-activating compounds for the treatment of neurodegenerative diseases

 #13
20190161462
2019-05-30

Methods and compositions for wound healing

 #14
20180360795
2018-12-20

Fumigillol compounds and methods of making and using same

 #15
20180354924
2018-12-13

Oxaspiro[2.5]octane derivatives and analogs

 #16
20180108944
2018-04-19

Graphene compound and manufacturing method thereof, electrolyte, and power storage device

 #17
20180072693
2018-03-15

Method for synthesizing a precursor of a single dairy-lactone isomer

 #18
20170349802
2017-12-07

Nano-hybrid lubricant and method thereof, and oil-based drilling fluid

 #19
20170342043
2017-11-30

Fumigillol compounds and methods of making and using same

 #20
20170305845
2017-10-26

Process for preparing 4[[(benzoyl)amino]sulphonyl]benzoyl chlorides and preparation of acylsulphamoylbenzamides

 #21
20170144981
2017-05-25

Methods and compositions for wound healing

 #22
20170044122
2017-02-16

Oxaspiro[2.5]Octane Derivatives and Analogs

 #23
20160264758
2016-09-15

Plasticizers for polymers

 #24
20160215215
2016-07-28

Nematic liquid crystal composition and liquid crystal display element including same

 #25
20160214929
2016-07-28

Process for preparing 4[[(benzoyl)amino]sulphonyl]benzoyl chlorides and preparation of acylsulphamoylbenzamides

 #26
20160068499
2016-03-10

Methods and compositions for wound healing

 #27
20160060236
2016-03-03

PKC-activating compounds for the treatment of neurodegenerative diseases

 #28
20150210660
2015-07-30

ALICYCLIC EPOXY COMPOUND AND METHOD FOR PRODUCING SAME

 #29
20150126489
2015-05-07

Fumigillol compounds and methods of making and using same

 #30
20150122800
2015-05-07

Cross-linked graphene networks

 #31
20140243537
2014-08-28

Process for the preparation of oseltamivir and methyl 3-epi-shikimate

 #32
20140005292
2014-01-02

Polymerizable (photosensitive or reactive) cyano-containing compound, a dye, and colored photosensitive composition

 #33
20130310451
2013-11-21

Tricyclic lactones for treatment of cancer

 #34
20130244325
2013-09-19

Mitochondrial targeted stimulators of apoptosis

 #35
20130243868
2013-09-19

Formulations comprising T3 nanoparticles

 #36
20130184477
2013-07-18

Derivative of epichlorohydrin of natural origin

 #37
20130158046
2013-06-20

BIOCOMPATIBLE BIODEGRADABLE FUMAGILLIN ANALOG CONJUGATES

 #38
20130005937
2013-01-03

Method for preparing polyols and products obtained

 #39
20120149807
2012-06-14

Diepoxy compound, process for producing same, and composition containing the diepoxy compound

 #40
20120149768
2012-06-14

PKC-activating compounds for the treatment of neurodegenerative diseases

 #41
20120029217
2012-02-02

Process for producing epoxy compound

 #42
20110200936
2011-08-18

Salt and photoresist composition containing the same

 #43
20110178305
2011-07-21

PROCESS FOR THE PREPARATION OF 3,4-EPOXY-2-AMINO-1-SUBSTITUTED BUTANE DERIVATIVES AND INTERMEDIATE COMPOUNDS THEREOF

 #44
20110142947
2011-06-16

Formulations

 #45
20110086185
2011-04-14

Polymerizable liquid crystal compound and its polymer

 #46
20110009652
2011-01-13

Process for production of epoxy compound

 #47
20100113664
2010-05-06

Asymmetric Cyclic Diester Compounds

 #48
20100076166
2010-03-25

Cyclic olefins compounds, polymers comprising the same and liquid crystal alignment films including the polymers

 #49
20100022645
2010-01-28

PKC-activating compounds for the treatment of neurodegenerative diseases

 #50
20090312470
2009-12-17

Asymmetric Cyclic Diester Compounds

 #51
20090148396
2009-06-11

Biocompatible biodegradable fumagillin analog conjugates

 #52
20090030217
2009-01-29

Production process of bifunctional epoxy monomer by selective oxidation of diolefin compound

 #53
20080004425
2008-01-03

Cycloaliphatic polyepoxy compounds and preparation thereof

 #54
20070203219
2007-08-30

Production of dolasetron

 #55
20070203177
2007-08-30

Forms of dolasetron mesylate and processes for their preparation

 #56
20070203176
2007-08-30

Crystalline forms of dolasetron base and processes for preparation thereof

 #57
20070203175
2007-08-30

Productioin of dolasetron

 #58
20070197807
2007-08-23

Derivatives of unsaturated, cyclic organic acids

 #59
20070042191
2007-02-22

Tougher cycloaliphatic epoxide resins

 #60
20060173072
2006-08-03

Shogaol compound and tyrosinase activity inhibitor comprising the compound